Monitoring individuals with HIV infection/AIDS involves the use of expensive tools, which are not readily available in resource-limited settings. In April 2002, the World Health Organization (WHO) recommended that, when a CD4 cell count is not available or is not affordable to obtain for affected individuals, a total lymphocyte count of less than 1000-1200 lymphocytes/mm 3 in individuals with stage II or III disease be used as an indication to initiate antiretroviral therapy [1]. This recommendation was based on rigorous evaluation of data obtained almost exclusively from developed countries [2] [3] [4] . In 2001, Akanmu et al. [5] reported that total lymphocyte count could not be used as a surrogate for CD4 cell count in mon- itoring response to antiretroviral therapy. There is limited information on the relationship between CD4 cell counts and total lymphocyte count and other hematological indices in resource-limited settings. This study was initiated to ascertain the reliability of total lymphocyte count as a substitute for CD4 cell count, determine the relationship of other hematological indices with CD4 cell count, and observe the influence of the person's sex, if any, on data collected.
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Patients, materials, and methods. All consenting HIV-1-seropositive individuals, both symptomatic and asymptomatic, were recruited over a 12-month period and were investigated. Hematological indices, such as hematocrit, WBC count, and WBC differential count, were obtained using an automated cell counter (Advia-60; Advia). CD4 lymphocyte count was obtained using the Dynal Manual CD4 kit. Total lymphocyte count was calculated from the WBC count and the differential count for lymphocytes. The sensitivity and specificity of total lymphocyte count as a predictor of CD4 cell count were calculated together with the likelihood ratio [5] . Data are presented as with 95% CIs and are analyzed using mean ‫ע‬ SD differential statistics.
Results. A total of 151 results from 109 HIV-1-seropositive individuals with a mean age of years were analyzed. 38.5 ‫ע‬ 11.6 There were significantly more female patients than male patients (ratio of male to female patients, 1:1.4; Table 2 shows that 225 ‫ע‬ 175 male subjects were significantly older than female subjects ( vs. years; ) and had a higher 45.4 ‫ע‬ 11 34.7 ‫ע‬ 10 P ! .0001 mean hematocrit than female subjects (34% ‫ע‬ 7% vs. 30% ‫ע‬ 6.5%;
), but the other parameters showed no signif-P ! .01 icant difference between the sexes.
Correlations between CD4 cell count and the other parameters (table 3) showed that total lymphocyte count (r p r p 0.340 P ! .01 results (73.5%; 64 female and 47 male patients), the total lymphocyte count was у1200 lymphocytes/mm 3 ; of these patients, 42 (37.8%; 21 female and 21 male) had a CD4 cell count of !200 cells/mm 3 ( figure 1 ). The sensitivity of total lymphocyte count as a predictor of CD4 cell count was 45.5%, and the specificity was 62.2%. The likelihood ratio was 0.83.
Discussion. The mean values obtained in this laboratorybased study were similar to values reported elsewhere (table 1) [5, 6] . The correlation coefficient for CD4 cell count and hematocrit was not as strong as that for CD4 cell count and total lymphocyte count (table 3) , and, therefore, hematocrit cannot be used as a predictor of CD4 cell count, particularly in patients with an advanced state of immunosuppression. Contrary to expectation, total lymphocyte count did not correlate strongly with CD4 cell count, as was reported by Beck et al. [2] in 1996, and there was not a significant difference between male and female subjects with regard to CD4 cell count [7, 8] . Indeed, this study corroborates findings of other studies [5, 9] that total lymphocyte count was not a surrogate for CD4 cell count and that it was "an imperfect predictor of CD4 count" [9] . Again, support for this was provided by the sensitivity of total lymphocyte count as a predictor of CD4 cell count, which was !50% in this study. It was also observed that ∼1 of 3 results involving a total lymphocyte count of 1200 lymphocytes/mm 3 had a CD4 cell count of !200 cells/mm 3 . This means that, at diagnosis, too many individuals would have gone untreated if the WHO guideline for the use of total lymphocyte count instead of CD4 cell count was implemented, and this would be unethical. Total lymphocyte count is not a substitute for CD4 cell count in a resource-limited setting: 1 in 3 individuals would be deprived of needed medication if a total lymphocyte count of 1200 cells/mm 3 were used, as recommended by the WHO. CD4 cell counts per se were similar for male and female patients. Other hematological indices have not been found to be useful predictors of CD4 cell count, which will have to remain the gold standard for monitoring HIV-infected individuals, even in a resource-limited setting, until another readily available surrogate marker is found. The search continues.
